Campbell to host Cannabinoid Collaborative Conference at Raleigh campus

Campbell University will host the Carolina Cannabinoid Collaborative (CCC) 2018 Conference this weekend at the downtown Raleigh campus.

From Nov. 9-11, scientists, clinicians and students who study or are interested in learning more about the field of cannabinoids will meet to discuss the latest research.

With evolving policies and increasing research into cannabinoids’ therapeutic potentials, the conference has grown in numbers and will showcase recent data from some of the field’s top researchers. This year, attendees are expected from as far away as Canada, Nigeria and New Zealand.

“One purpose of this event is to bring together people interested in cannabinoid science for a weekend of networking that may lead to inter-institutional collaborations,” said Vice Chair and Associate Professor of Pharmaceutical Sciences Chris Breivogel. “Hosting will give Campbell University some recognition in this area and beyond.”

The 2018 CCC speakers include individuals from North Carolina, Connecticut, Kentucky and California who have expertise on central nervous system, cardiovascular and medicinal effects of cannabinoids. Not only will attendees will hear presentations from leaders in the field, but all registrants were invited to submit abstract submissions and present their own research during a session of the conference. 

Faculty from various departments have collaborated to organize CCC 2018, including faculty from Campbell University’s College of Pharmacy & Health Sciences (Chris Breivogel, David Eagerton, Pius Fasinu, Steve Holly, Victor Pulgar and Krisztian Toth), the School of Osteopathic Medicine (Bonnie Brenseke and Khalil Eldeeb) and the College of Arts & Sciences (John Bartlett).